InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by McGroddy-Goetz Kathleen, Director. Director active across 2 companies, notably TANDEM DIABETES CARE INC. Aggregated, 9 filings have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €59k. History available since 8 June 2021. The latest transaction was filed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to McGroddy-Goetz Kathleen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
4,387 shares@ US$20.6422.8% of flowCommon StockSEC:0001438133-25-000108:0
4,434 shares@ US$51.7360.3% of flowCommon StockSEC:0001438133-24-000124:0
1,000 shares@ US$21.4533.9% of flowCommon StockSEC:0001438133-23-000197:0
Canonical exit: 14 Dec 2023 (T+90)
1,220 shares0Common StockSEC:0001438133-23-000135:0
2,757 shares0Common StockSEC:0001438133-23-000107:0
1,220 shares0Common StockSEC:0001438133-22-000158:0
2,021 shares0Common StockSEC:0001438133-22-000099:0
405 shares@ US$106.0011.2% of flowCommon StockSEC:0001438133-22-000039:0
1,219 shares0Common StockSEC:0001438133-21-000095:0
9 of 9 declarations
About McGroddy-Goetz Kathleen
Kathleen McGroddy-Goetz is a Board Member at TANDEM DIABETES CARE INC. She contributes to the strategic direction of the company, leveraging her experience in the healthcare sector. Her role includes overseeing operations and making key decisions.
